Exports, domestic demand to drive pharma growth
Business Standard|December 24, 2024
Healthy exports and steady domestic demand will drive pharma growth.

Steady raw material prices and higher volumes are expected to support margins, while credit profiles remain stable.

After growing 10 per cent in the last financial year, the pharmaceutical sector is projected to expand 8-10 per cent in this financial year and 9-11 per cent in the next, led by sustained overseas demand, particularly for formulations, and steady domestic demand. The international market, accounting for 53 per cent of the industry's revenue, surged 13 per cent in FY24 (in rupee terms) and is projected to grow 10-12 per cent in FY25 and 11-13 per cent in the next. This growth is driven by new product launches, better pricing, and diversification into untapped markets.

This story is from the December 24, 2024 edition of Business Standard.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

This story is from the December 24, 2024 edition of Business Standard.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

MORE STORIES FROM BUSINESS STANDARDView All
NSO REPORT ON UNINCORPORATED SECTOR Fresh job creation slows in 2023-24
Business Standard

NSO REPORT ON UNINCORPORATED SECTOR Fresh job creation slows in 2023-24

Fresh employment generation in the unincorporated sector slowed in the October 2023-September 2024 period, with additional job creation dipping to 10.97 million during this interval as compared to the equivalent figure of 11.74 million in October 2022-September 2023.

time-read
2 mins  |
December 25, 2024
RBI report sees signs of economic recovery in Q3
Business Standard

RBI report sees signs of economic recovery in Q3

Cites strong festival season, rural demand pickup; FPI flows positive

time-read
2 mins  |
December 25, 2024
Pioneer of parallel cinema dies at 90
Business Standard

Pioneer of parallel cinema dies at 90

Veteran filmmaker Shyam Benegal, who heralded the Indian parallel cinema movement in the 1970s and 1980s with films such as Ankur, Nishant and Manthan, died on Monday, his daughter Pia said. He was 90.

time-read
2 mins  |
December 24, 2024
How tech is changing the landscape of elder care
Business Standard

How tech is changing the landscape of elder care

The concluding part of the silver economy series looks at innovative apps and wearables that are empowering seniors and their families

time-read
2 mins  |
December 24, 2024
ALGO RHYTHM AND BLUES
Business Standard

ALGO RHYTHM AND BLUES

Can Sebi's draft rules on algorithm-based trading level the playing field between institutional and non-institutional investors?

time-read
4 mins  |
December 24, 2024
Business Standard

AVOIDING MIS-SELLING BY MF DISTRIBUTORS Say no to NFOs, buy direct plans and seek advice from Sebi RIAs

The Securities and Exchange Board of India (Sebi) has implemented a new rule to curb unnecessary portfolio churn by distributors, usually done during the launch of new fund offers (NFOs) to pocket higher commissions.

time-read
2 mins  |
December 24, 2024
Amber Enterprises posts sharpest rise in 2 mths
Business Standard

Amber Enterprises posts sharpest rise in 2 mths

13% gains driven by block deal in which 1% equity changed hands

time-read
2 mins  |
December 24, 2024
Business Standard

NEW LISTINGS ADD 3% TO INDIA'S MCAP IN 2024

New listings through initial public offerings (IPOs) in 2024 contributed nearly 3 per cent (₹14 trillion) to India's market capitalisation, surpassing last year's contribution of 1.4 per cent (₹5 trillion).

time-read
1 min  |
December 24, 2024
Business Standard

Weak management commentary weighs on Siemens stock

Siemens's share price has lost ground in the past few sessions following weak management commentary.

time-read
2 mins  |
December 24, 2024
Business Standard

Mkts stage sharp recovery after five days of fall

Equity benchmark indices Sensex and Nifty rebounded sharply on Monday after five days of steep decline amid value buying at lower levels and a rally in global markets.

time-read
1 min  |
December 24, 2024